Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2‐12, in Healthy Dogs and Dogs with Clinical Recurrent UTI

BACKGROUND: Antimicrobial resistance is an emerging problem. HYPOTHESIS/OBJECTIVE: To investigate the safety and efficacy of a live biotherapeutic product, ASB E. coli 2‐12 for UTI treatment. ANIMALS: Six healthy research dogs; nine client‐owned dogs with recurrent UTI. METHODS: Prospective noncontr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Vet Intern Med
Main Authors: Segev, G., Sykes, J.E., Klumpp, D.J., Schaeffer, A.J., Antaki, E.M., Byrne, B.A., Yaggie, R.E., Westropp, J.L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
SMALL ANIMAL
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5787194/
https://ncbi.nlm.nih.gov/pubmed/29243301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14851
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados